RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma
Backgrounds: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and the second leading cause of death among all cancers. The Ras-associated binding (Rab) proteins constitute the largest family of the Ras superfamily of small GTPases, which mainly mediate membrane traffick...
Main Authors: | Hao Peng, Erwei Zhu, Jitao Wang, Xuanlong Du, Chonggao Wang, Meng Yang, Yewei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.989655/full |
Similar Items
-
RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma
by: Hao Peng, et al.
Published: (2022-05-01) -
scRNA-Seq Analysis Revealed CAFs Regulating HCC Cells via PTN Signaling
by: Lin W, et al.
Published: (2024-11-01) -
ATP6V1F is a novel prognostic biomarker and potential immunotherapy target for hepatocellular carcinoma
by: Xinyao Hu, et al.
Published: (2023-08-01) -
Prognostic Lysosome-Related Biomarkers for Predicting Drug Candidates in Hepatocellular Carcinoma: An Insilco Analysis
by: Xu J, et al.
Published: (2023-03-01) -
Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma
by: Fukai Wen, et al.
Published: (2023-03-01)